|
|
|
Insider
Information: |
Loy Bertrand |
Relationship: |
Director |
City: |
Acton |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
323,083 |
|
Indirect Shares
|
499,633 |
|
|
Direct
Value |
$34,692,280 |
|
|
Indirect Value
|
$1,383,983 |
|
|
Total
Shares |
822,716 |
|
|
Total
Value |
$36,076,263 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
7
|
0
|
Stock
price went up :
|
7
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
7.0
|
0.0
|
Percentage
Gain/Loss : |
71.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Entegris Inc |
ENTG |
President & CEO, Direc... |
2024-04-01 |
263,068 |
2021-08-11 |
0 |
Premium* |
|
BTU International Inc |
BTUI |
Director |
2016-01-26 |
3,440 |
2016-01-26 |
0 |
Premium* |
|
Harvard Bioscience Inc |
HBIO |
Director |
2024-05-21 |
56,575 |
2024-05-21 |
499,633 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
177 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,600 |
191,550 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-09-11 |
4 |
B |
$3.01 |
$46,926 |
D/D |
15,590 |
138,674 |
2.39 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-09-12 |
4 |
B |
$3.07 |
$34,682 |
D/D |
11,297 |
149,971 |
2.39 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-09-13 |
4 |
B |
$3.11 |
$22,927 |
D/D |
7,372 |
157,343 |
2.39 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-11-08 |
4 |
B |
$2.64 |
$17,466 |
D/D |
6,616 |
163,959 |
2.39 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-11-11 |
4 |
B |
$2.59 |
$33,294 |
D/D |
12,855 |
176,814 |
2.39 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-11-12 |
4 |
B |
$2.51 |
$26,553 |
D/D |
10,579 |
187,393 |
2.39 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2019-11-13 |
4 |
B |
$2.52 |
$15,372 |
D/D |
6,100 |
193,493 |
2.39 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
223,493 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2020-06-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,767) |
221,726 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
28,100 |
249,826 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,300 |
251,126 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
21,300 |
272,426 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
286,826 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2021-12-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,401 |
288,227 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,489 |
292,716 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
47,493 |
340,209 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-08-18 |
4 |
B |
$3.19 |
$3,672 |
D/D |
1,151 |
341,360 |
2.31 |
% |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-08-19 |
4 |
B |
$3.28 |
$31,514 |
D/D |
9,608 |
350,968 |
2.39 |
% |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-08-22 |
4 |
B |
$3.16 |
$15,541 |
D/D |
4,918 |
355,886 |
2.39 |
% |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-08-23 |
4 |
B |
$3.23 |
$28,873 |
D/D |
8,939 |
364,825 |
2.39 |
% |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-08-24 |
4 |
B |
$3.23 |
$55,850 |
D/D |
17,291 |
382,116 |
2.39 |
% |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-08-25 |
4 |
B |
$3.34 |
$27,535 |
D/D |
8,244 |
390,360 |
2.39 |
% |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-08-26 |
4 |
B |
$3.41 |
$31,682 |
D/D |
9,291 |
399,651 |
2.39 |
% |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2022-09-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(108,715) |
0 |
0 |
- |
|
177 Records found
|
|
Page 7 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|